Proprietary Database definition
Examples of Proprietary Database in a sentence
The Customer must notify WRG within thirty (30) days after the effective date of the termination or expiration of this Agreement, if the Customer requires the Proprietary Database data in the System to be transferred to the Customer.
It is also understood and agreed that Hyseq presently owns the Hyseq Proprietary Database and intends to expand that database, and that Hyseq may in the future engage, whether independently or in collaboration with third parties, in the research, development and commercialization of products outside of the Exclusive Field based on information contained in the Hyseq Proprietary Database.
In performing Research for Chiron pursuant to this Agreement, Hyseq shall utilize, to the extent relevant, all information contained in the Hyseq Proprietary Database now or at any time during the Collaboration Term.
All employees are trained to use our Proprietary Database of over 52,000 available candidates, and to identify candidates with the skills requested by clients.
Database Capacity – The capacity of the Proprietary Database to handle the number of required registered users and/or concurrent users.
DECOGEN DataManager software provides full access to the STRENGTH Database and has tools for importing a variety of data including SNPs, genotypes and Haplotypes for any gene whose structure is in the STRENGTH Database or the AstraZeneca Proprietary Database.
Subject to the terms of this Agreement, Genaissance hereby grants to ▇▇▇▇▇▇▇ a worldwide [**] license, [**], under the Genaissance Patent Rights and Genaissance Know-How to use one or more HAP Markers derived from the ▇▇▇▇▇▇▇ Proprietary Database (and any corresponding Isogene Clones ordered by ▇▇▇▇▇▇▇ pursuant to section 3.7 hereof) solely for internal research and development purposes.
AstraZeneca shall pay Genaissance for installing clinical data and genetic data from the AstraZeneca clinical trials into the AstraZeneca Proprietary Database, and for building Haplotypes from such genetic data, for a fee of [**] dollars ($[**]) for the entire Research Study.
Within about [**] from receipt of the genotyping results, Genaissance will send AstraZeneca the HAP-TM- Marker information obtained for the disease cohort along with instructions for (i) installing this information in the AstraZeneca Proprietary Database and (ii) enabling the clinical features (the "Second Installation Date").